{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:30:56Z","timestamp":1793421056195,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canep.2026.103210","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:35:11Z","timestamp":1788204911000},"page":"103210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nationwide study of cutaneous basal cell carcinoma incidence trends in Norway, 2012\u20132022"],"prefix":"10.1016","volume":"105","author":[{"given":"Trude E.","family":"Robsahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9314-2253","authenticated-orcid":false,"given":"Anna","family":"Skog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-2758","authenticated-orcid":false,"given":"Marit B.","family":"Veier\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Roscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6732-0658","authenticated-orcid":false,"given":"Trine","family":"Brevig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghiasvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-1889","authenticated-orcid":false,"given":"Bj\u00f8rn","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2026.103210_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","article-title":"The epidemiology of UV induced skin cancer","volume":"63","author":"Armstrong","year":"2001","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.canep.2026.103210_bib2","series-title":"Cancer Epidemiology and Prevention","first-page":"249","article-title":"Ultraviolet radiation","author":"Green","year":"2018"},{"key":"10.1016\/j.canep.2026.103210_bib3","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1055-9965.EPI-20-1815","article-title":"Lifetime ambient UV radiation exposure and risk of basal cell carcinoma by anatomic site in a nationwide U.S. cohort 1983-2005","volume":"30","author":"Little","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2026.103210_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.canep.2026.103210_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bjd.15321","article-title":"Epidemiology of basal cell carcinoma: scholarly review","volume":"177","author":"Verkouteren","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.canep.2026.103210_bib6","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3212203","article-title":"Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk","volume":"32","author":"Olsen","year":"2022","journal-title":"Public. Health Res. Pract."},{"issue":"12","key":"10.1016\/j.canep.2026.103210_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch. Dermatol."},{"issue":"7","key":"10.1016\/j.canep.2026.103210_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/14737140.2023.2219449","article-title":"Treatment of basal cell carcinoma with intralesional interferon alfa-2b: an open-label clinical trial","volume":"23","author":"Maleki","year":"2023","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.canep.2026.103210_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2340\/00015555-1938","article-title":"Societal cost of skin cancer in Sweden in 2011","volume":"95","author":"Eriksson","year":"2015","journal-title":"Acta Derm. Venereol."},{"issue":"9","key":"10.1016\/j.canep.2026.103210_bib10","article-title":"The economics of skin cancer: an analysis of medicare payment data","volume":"4","author":"Chen","year":"2016","journal-title":"Plast. Reconstr. Surg. Glob. Open."},{"key":"10.1016\/j.canep.2026.103210_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canep.2018.08.004","article-title":"Skin cancer healthcare impact: a nation-wide assessment of an administrative database","volume":"56","author":"Duarte","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2026.103210_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/bjd\/ljad065","article-title":"The important but difficult exercise of getting valid descriptive skin cancer data","volume":"188","author":"De Vries","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canep.2026.103210_bib13","unstructured":"Internal rules for multiple primary cancers (ICD-O Third Edition). Internal Report No. 2004\/02, International Agency for Research on Cancer (IARC), Lyon, France. www.iarc.com.fr\/images\/doc\/MPrules_july2004.pdf (Accessed 7 May 2025)."},{"issue":"7","key":"10.1016\/j.canep.2026.103210_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.135.7.781","article-title":"Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995","volume":"135","author":"Hannuksela-Svahn","year":"1999","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.canep.2026.103210_bib15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ijc.25411","article-title":"Trends in the incidence of nonmelanoma skin cancer in Denmark 1978\u20132007: rapid incidence increase among young Danish women","volume":"127","author":"Birch-Johansen","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2026.103210_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/00015555-2282","article-title":"Basal cell carcinoma is as common as the sum of all other cancers: implications for treatment capacity","volume":"96","author":"Holm","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"10.1016\/j.canep.2026.103210_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/bjd.20964","article-title":"Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study","volume":"186","author":"Kappelin","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canep.2026.103210_bib18","series-title":"Norwegian Institute of Public Health. Cancer in Norway 2024 - Cancer Incidence, Mortality, Survival and Prevalence in Norway","author":"Cancer Registry of Norway","year":"2025"},{"key":"10.1016\/j.canep.2026.103210_bib19","series-title":"Global Cancer Observatory: Cancer Today (version 1.1)","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.canep.2026.103210_bib20","series-title":"Stata Statistical Software: Release 18","author":"StataCorp","year":"2023"},{"key":"10.1016\/j.canep.2026.103210_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/bjd\/ljae201","article-title":"Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study","volume":"191","author":"Hammas","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.canep.2026.103210_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12672-021-00426-5","article-title":"Temporal trends in the incidence rates of keratinocyte carcinomas from 1978 to 2018 in Tasmania, Australia: a population-based study","volume":"12","author":"Ragaini","year":"2021","journal-title":"Discov. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2026.103210_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bjd\/ljad033","article-title":"British association of dermatologists national disease registration service steering committee. 'Get data out' skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England","volume":"188","author":"van Bodegraven","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.canep.2026.103210_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jdv.18774","article-title":"J. Basal cell carcinoma: epidemiological impact of clinical versus histopathological diagnosis","volume":"37","author":"Backman","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.canep.2026.103210_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2025.18749","article-title":"Keratinocyte carcinoma: a review","volume":"335","author":"Wehner","year":"2026","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.canep.2026.103210_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bjd\/ljaf206","article-title":"Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US radiologic technologist cohort","volume":"193","author":"Mai","year":"2025","journal-title":"Brit J. Dermatol."},{"key":"10.1016\/j.canep.2026.103210_bib27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-14-0251","article-title":"Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort","volume":"2388","author":"McDonald","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.canep.2026.103210_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.canep.2026.103210_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/1055-9965.EPI-17-0003","article-title":"Spectrum of immune-related conditions associated with risk of keratinocyte cancers among elderly adults in the United States","volume":"26","author":"Yanik","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:58:42Z","timestamp":1793419122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782126002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"alternative-id":["S1877782126002262"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.103210","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nationwide study of cutaneous basal cell carcinoma incidence trends in Norway, 2012\u20132022","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.103210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103210"}}